Jonathan Yingling

Direttore Tecnico/Scientifico/R&S presso ARCUS BIOSCIENCES, INC.

55 anni

Health Technology

Consumer Services

Profilo

Jonathan Yingling is currently the Chief Scientific Officer at Arcus Biosciences, Inc. He previously held positions as Vice President-Oncology Discovery at Bristol Myers Squibb Co. from 2013 to 2015, and as Chief Scientific Officer & Senior Vice President at Idera Pharmaceuticals, Inc. from 2018 to 2020.
He also served as the Chief Scientific Officer at DNIB Unwind, Inc. Dr. Yingling completed his undergraduate degree at The College of William & Mary and obtained his doctorate from Duke University School of Medicine in 2016.

Posizioni attive di Jonathan Yingling

Società	Posizione	Inizio
ARCUS BIOSCIENCES, INC.	Direttore Tecnico/Scientifico/R&S	01/01/2020

Tutte le posizioni attive di Jonathan Yingling

Precedenti posizioni note di Jonathan Yingling

Società	Posizione	Fine
Idera Pharmaceuticals, Inc. Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.	Direttore Tecnico/Scientifico/R&S	31/01/2020
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	01/10/2015
DNIB UNWIND INC	Direttore Tecnico/Scientifico/R&S	-

Vedi nel dettaglio l'esperienza di Jonathan Yingling

Formazione di Jonathan Yingling

Duke University School of Medicine	Doctorate Degree
The College of William & Mary	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Jonathan Yingling

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
BRISTOL-MYERS SQUIBB COMPANY	Health Technology
ARCUS BIOSCIENCES, INC.	Health Technology

Aziende private	2
DNIB Unwind, Inc. DNIB Unwind, Inc. BiotechnologyHealth Technology DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Los Angeles, CA.	Health Technology
Idera Pharmaceuticals, Inc. Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.	Health Technology